The Difference in the Effects on Microalbuminuria Depending on the Order of GLP-1RA and SGLT2i Therapy in Type 2 Diabetes

被引：0
|
作者：
Ohara, Masaya
Motoyama, Koka
Tamai, Anna
Sakura, Takeshi
Yakushiji, Yosuke
Hosoi, Masayuki
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-545-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
545-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Glycaemic control and beta cell function in type 2 diabetes on SGLT2i and GLP-1RA combination therapy
    Martinez, R.
    Al-Jobory, H.
    Adams, J.
    Chavez-Velasquez, A.
    Triplitt, C.
    DeFronzo, R. A.
    Cersosimo, E.
    DIABETOLOGIA, 2017, 60 : S408 - S409
  • [2] GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
    Pablo, Aschner
    Evelyn, Blanc
    Claudia, Folino
    Yanina, Morosan A.
    CURRENT HYPERTENSION REVIEWS, 2021, 17 (02) : 149 - 158
  • [3] Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages
    Koike, Masao
    Saito, Hitoki
    Kohno, Genta
    Takubo, Masahiro
    Watanabe, Kentaro
    Ishihara, Hisamitsu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [4] The comparative effects of metabolic surgery, SGLT2i, or GLP-1RA in patients with obesity and type 2 diabetes: a retrospective cohort study
    Wu, Tingting
    Wong, Carlos K. H.
    Tang, Eric H. M.
    Man, Kenneth K. C.
    Wong, Simon K. H.
    Au, Ivan Chi Ho
    Tse, Emily T. Y.
    Chan, Esther W. Y.
    Grieve, Eleanor
    Wu, Olivia
    Ng, Enders K. W.
    Wong, Ian C. K.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2022, 18 (06) : 762 - 771
  • [5] Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity
    Terenzi, Daniella C.
    Bakbak, Ehab
    Teoh, Hwee
    Krishnaraj, Aishwarya
    Puar, Pankaj
    Rotstein, Ori D.
    Cosentino, Francesco
    Goldenberg, Ronald M.
    Verma, Subodh
    Hess, David A.
    CARDIOVASCULAR RESEARCH, 2024, 119 (18) : 2858 - 2874
  • [6] Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
    Khat, Dorrin Zarrin
    Husain, Mansoor
    CURRENT DIABETES REPORTS, 2018, 18 (07)
  • [7] Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA
    Dorrin Zarrin Khat
    Mansoor Husain
    Current Diabetes Reports, 2018, 18
  • [8] Comparative Safety and Effectiveness of GLP-1RA and SGLT2i Use in Adults with Type 2 Diabetes in US Clinical Practice
    Hoffman, Sarah R.
    Lanes, Stephan
    Quimbo, Tracey
    Papazian, Aanahit
    White, Jeff
    Fisher, Vicki
    Cziraky, Mark J.
    Crowley, Matthew J.
    Willey, Vincent
    DIABETES, 2024, 73
  • [9] Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes
    Vale, Catarina
    Lourenco, Ines Mariana
    Jordan, Gabriela
    Golovaty, Ilya
    Torres, Hugo
    Moin, Tannaz
    Buysschaert, Martin
    Neves, Joao Sergio
    Bergman, Michael
    DIABETES OBESITY & METABOLISM, 2024,
  • [10] Benefit of dual therapy with GLP-1 RA and SGLT2i on cardiovascular outcomes in type 2 diabetes
    Zareini, B.
    Gerds, T.
    Sorensen, K. K.
    Clemmensen, K. K. B.
    Kvist, K.
    David, J. -P.
    Torp-Pedersen, C.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S30 - S30
12345